Sleep apnea and the heart: Diagnosis and treatment

Reviews in Cardiovascular Medicine

Volumn 9, Issue 3, 2008, Pages 159-167

  Yumino, Dai ^a   Kasanuki, Hiroshi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Apneahypopnea index; Cardiovascular disease; Continuous positive airway pressure; Heart failure; Sleep apnea

Indexed keywords

ACETAZOLAMIDE; THEOPHYLLINE;

AORTA DISEASE; ATHEROSCLEROSIS; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CENTRAL SLEEP APNEA SYNDROME; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DRUG EFFICACY; ELECTROENCEPHALOGRAPHY; GOLD STANDARD; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; HYPERTENSION; NONHUMAN; OXYGEN THERAPY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PULMONARY HYPERTENSION; REVIEW; SLEEP APNEA SYNDROME; VASCULAR DISEASE;

CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CONTINUOUS POSITIVE AIRWAY PRESSURE; ELECTROENCEPHALOGRAPHY; HEART FAILURE; HUMANS; POLYSOMNOGRAPHY; SLEEP APNEA SYNDROMES; SLEEP APNEA, CENTRAL; TREATMENT OUTCOME;

EID: 53949088248     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:1378-1384.
2. Shahar E, Whitney CW, Redline S, et al. Sleepdisordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001; 163:19-25.
3. Javaheri S, Shukla R, Zeigler H, Wexler L. Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol. 2007;49:2028-2034.
4. Yumino D, Bradley TD. Central sleep apnea and Cheyne-Stokes respiration. Proc Am Thorac Soc. 2008;5:226-236.
5. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993, 328:1230-1235.
6. Martinez-Garcia MA, Gomez-Aldaravi R, Soler-Cataluna JJ, et al. Positive effect of CPAP treatment on the control of difficult-to-treat hypertension. Eur Respir J. 2007;29:951-957.
7. Javaheri S. Sleep disorders in systolic heart failure: a prospective study of 100 male patients. The final report. Int J Cardiol 2006;106:21-28.
8. Bradley TD, Floras JS. Sleep apnea and heart failure: part I: obstructive sleep apnea. Circulation. 2003;107:1671-1678.
9. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96:1897-1904.
10. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365:1046-1053.
11. Drager LF, Bortolotto LA, Lorenzi MC, et al. Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med. 2005; 172:613-618.
12. Drager LF, Bortolotto LA, Figueiredo AC, et al. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med. 2007; 176:706-712.
13. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
14. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet. 2002;359:204-210.
15. Barbé F, Mayoralas LR, Duran J, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness: a randomized, controlled trial. Am Intern Med. 2001;134:1015-1023.
16. Yumino D, Tsurumi Y, Takagi A, et al. impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol. 2007;99:26-30.
17. Peled N, Abinader EG, Pillar G, et al. Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: effects of continuous positive air pressure treatment. J Am Coll Cardiol. 1999;34:1744-1749.
18. Cistulli PA, Wilcox I, Jeremy R, Sullivan CE. Aortic root dilatation in Marfan's syndrome: a contribution from obstructive sleep apnea? Chest. 1997;111:1763-1766.
19. Peters J, Kindred MK, Robotham JL. Transient analysis of cardiopulmonary interactions. I. Diastolic events. J Appl Physiol. 1988;64:1506-1517.
20. Serizawa N, Yumino D, Takagi A, et al. Obstructive sleep apnea is associated with greater thoracic aortic size. J Am Coll Cardiol. 2008;52:885-886.
21. Weitzenblum E, Krieger J, Apprill M, et al. Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis. 1988;138:345-349.
22. Arias MA, Garcia-Rio F, Alonso-Fernandez A, et al. Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study. Eur Heart J. 2006;27:1106-1113.
23. Mehra R, Benjamin EJ, Shahar E, et al. Association of nocturnal arrhythmias with sleepdisordered breathing: the Sleep Heart Health Study. Am I Respir Crit Care Med. 2006;173:910-916.
24. Becker H, Brandenburg U, Peter JH, Von Wichert P. Reversal of sinus arrest and atrioventricular conduction block in patients with sleep apnea during nasal continuous positive airway pressure. Am f Respir Crit Can Med. 1995;151:215-218.
25. Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (ACC/AHA/NASPE committee to update the 1998 pacemaker guidelines). Circulation. 2002;106:2145-2161.
26. Kanagala R, Murali NS, Friedman PA, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003;107:2589-594.
27. Mitchell AR, Spurrell PA, Sulke N. arcadian variation of arrhythmia onset patterns in patients with persistent atrial fibrillation. Am Heart J. 2003;146:902-907.
28. Garni AS, Howard DE, Olson EJ, Somers VK. Daynight pattern of sudden death in obstructive sleep apnea. N Engl J Med. 2005;352:1206-1214.
29. Ryan CM, Usui K, Floras JS, Bradley TD. Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. Thorax. 2005;60:781-85.
30. Gomita K, Yumino D, Ajiro Y, et al. Assessment of the fluctuation of late potential and QT interval during sleep in a patient with endstaged hypertrophie cardiomyopathy who has nocturnal ventricular tachycardia and obstructive sleep apnea. Heart Rhythm. 2006;3: S339-S340.
31. Kaneko Y, Floras JS, Usui K, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med. 2003; 348:1233-1241.
32. Parker JD, Brooks D, Kozar LF, et al. Acute and chronic effects of airway obstruction on canine left ventricular performance. Am J Respir Crit Care Med. 1999;160:1888-1896.
33. Usui K, Parker JD, Newton GE, et al. Left ventricular structural adaptations to obstructive sleep apnea in dilated cardiomyopathy. Am J Respir Crit Care Med. 2006;173:1170-1175.
34. Tkacova R, Niroumand M, Lorenzi-Filho G, Bradley TD. Overnight shift from obstructive to central apneas in patients with heart failure: role of PCO2 and circulatory delay. Circulation. 2001;103:238-243.
35. 2 below eupnoea as a determinant of ventilatory stability in sleep. J Physiol. 2004;560:1-11.
36. Tsagalou EP, Anastasiou-Nana MI, Terrovitis JV, et al. The long-term survival benefit conferred by intermittent dobutamine infusions and oral amiodarone is greater in patients with idiopathic dilated cardiomyopathy than with ischemic heart disease. Int J Cardiol. 2006;108:244-250.
37. Phillips BG, Hisel TM, Kato M, et al. Recent weight gain in patients with newly diagnosed obstructive sleep apnea. J Hypertens. 1999; 17:1297-1300.
38. Kushida CA, Iittner MR, Hirshkowitz M, et al. Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep. 2006;29:375-380.
39. Garrigue S, Bordier P, Jais P, et al. Benefit of atrial pacing in sleep apnea syndrome. N Engl J Med. 2002;346:404-412.
40. Javaheri S, Parker TJ, Wexler L, et al Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med. 1996;335:562-567.
41. Javaheri S. Acetazolamide Improves central sleep apnea in heart failure: a double-blind. prospective study. Am J Respir Crit Care Med. 2006;173:234-237.
42. Arzt M, Bradley TD. Treatment of sleep apnea in heart failure. Am J Respir Crit Care Med. 2006; 173:1300-1308.
43. Bradley TD, Logan AG, Kimoff RJ, et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med. 2005;353:2025-2033.
44. Arzt M, Floras JS, Logan AG, et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation. 2007;115:3173-3180.
45. Wang H, Parker JD, Newton GE, et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol. 2007;49:1625-1631.